Literature DB >> 17630198

NF-kappaB signaling pathway, not IFN-beta/STAT1, is responsible for the selenium suppression of LPS-induced nitric oxide production.

Cheol-Heui Yun1, Jae Seung Yang, Seok-Seong Kang, Young Yang, Jung Hyo Cho, Chang Gue Son, Seung Hyun Han.   

Abstract

Upon stimulation of macrophages with lipopolysaccharide (LPS), Toll-like receptor 4 recognizes LPS, leading to expression of inducible nitric oxide synthase (iNOS), via MyD88/NF-kappaB and TRIF/IFN-beta/STAT pathways. Although selenium (Se) was reported to inhibit nitric oxide (NO) production, it is unclear which signaling pathway is inhibited by Se. Here, we investigated how Se inhibits NO production in LPS-stimulated RAW 264.7 cells. When the cells were pretreated with Se for 1 h followed by LPS treatment, iNOS mRNA expression and subsequent NO production declined significantly in a dose-dependent manner. Se inhibited IkappaBalpha degradation in the cytosol and NF-kappaB binding to its recognition site in the nucleus of the LPS-stimulated cells. Meanwhile, Se did not inhibit IFN-beta mRNA induction or STAT1 phosphorylation in the LPS-stimulated cells. These results suggest that Se down-regulates iNOS gene expression and NO production in the LPS-stimulated macrophages through inhibition of the NF-kappaB activation pathway but not the IFN-beta/STAT1 signaling pathway.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17630198     DOI: 10.1016/j.intimp.2007.05.002

Source DB:  PubMed          Journal:  Int Immunopharmacol        ISSN: 1567-5769            Impact factor:   4.932


  7 in total

1.  Selenomethionine inhibits IL-1β inducible nitric oxide synthase (iNOS) and cyclooxygenase 2 (COX2) expression in primary human chondrocytes.

Authors:  A W M Cheng; T V Stabler; M Bolognesi; V B Kraus
Journal:  Osteoarthritis Cartilage       Date:  2010-10-28       Impact factor: 6.576

2.  Systemic treatment with alpha-tocopherol and/or sodium selenite decreases the progression of experimental periodontitis.

Authors:  Nurgül Bas; Nezahat Arzu Kayar; Z Füsun Baba; Mustafa Cihat Avunduk; Seyfullah Haliloğlu; Nilgün Özlem Alptekin
Journal:  Clin Oral Investig       Date:  2020-09-28       Impact factor: 3.573

Review 3.  Nitric oxide as a target of complementary and alternative medicines to prevent and treat inflammation and cancer.

Authors:  Lorne J Hofseth
Journal:  Cancer Lett       Date:  2008-04-25       Impact factor: 8.679

4.  NF-kappaB promotes iNOS and VEGF expression in salivary gland adenoid cystic carcinoma cells and enhances endothelial cell motility in vitro.

Authors:  Jiali Zhang; Bin Peng
Journal:  Cell Prolif       Date:  2009-04       Impact factor: 6.831

5.  Macrophage-biomimetic porous Se@SiO2 nanocomposites for dual modal immunotherapy against inflammatory osteolysis.

Authors:  Cheng Ding; Chuang Yang; Tao Cheng; Xingyan Wang; Qiaojie Wang; Renke He; Shang Sang; Kechao Zhu; Dongdong Xu; Jiaxing Wang; Xijian Liu; Xianlong Zhang
Journal:  J Nanobiotechnology       Date:  2021-11-22       Impact factor: 10.435

6.  Macrophage Bactericidal Activities against Staphylococcus aureus Are Enhanced In Vivo by Selenium Supplementation in a Dose-Dependent Manner.

Authors:  Mourad Aribi; Warda Meziane; Salim Habi; Yasser Boulatika; Hélène Marchandin; Jean-Luc Aymeric
Journal:  PLoS One       Date:  2015-09-04       Impact factor: 3.240

7.  Alendronate promotes osteoblast differentiation and bone formation in ovariectomy-induced osteoporosis through interferon-β/signal transducer and activator of transcription 1 pathway.

Authors:  Xiaoqing Ma; Zhongyang Xu; Shaofeng Ding; Guangkun Yi; Qian Wang
Journal:  Exp Ther Med       Date:  2017-10-27       Impact factor: 2.447

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.